Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1999-9-24
pubmed:abstractText
Tetrapeptide derived major histocompatability (MHC) II ligands have been developed that contain no unadulterated peptide bonds. These are the 'least peptidic' ligands for any MHC protein yet reported.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
19
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2115-8
pubmed:dateRevised
2001-3-23
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands.
pubmed:affiliation
Department of Basic Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.
pubmed:publicationType
Journal Article